2792 J. Am. Chem. Soc., Vol. 119, No. 12, 1997
Lenz and Giese
6-N-Benzoyl-9-(2,5-di-O-(tert-butyldimethylsilyl)-3-O-(trimethyl-
silyl)-3-C-vinyl-â-D-xylofuranosyl)adenine (11). Nucleoside 10 (4.10
g, 6.55 mmol) was dissolved under argon in anhydrous CH2Cl2 (50
mL), treated with Horning’s silylation reagent25 (6 mL), and stirred
for 72 h at room temperature. The reaction mixture was partitioned
between H2O (150 mL) and Et2O (150 mL), the phases were separated,
and the organic phase was washed with H2O (2 × 150 mL) and brine
(100 mL). After drying over Na2SO4 and concentration in vacuo, 4.66
g (6.68 mmol) of crude silyl ether 11 was obtained as a white foam
which was employed directly in the next step without further purifica-
tion: Rf ) 0.32 (EtOAc/pentane 1:2), Rf ) 0.46 (EtOAc/CH2Cl2/pentane
1:1:2); 1H NMR (300 MHz, CDCl3) δ 9.04 (broad s, 1H), 8.82 (s, 1H),
8.36 (s, 1H), 8.05-8.02 (m, 2H), 7.64-7.51 (m, 3H), 6.07 (dd, J )
17.7, 11.3 Hz, 1H), 6.01 (d, J ) 1.7 Hz, 1H), 5.44 (d, J ) 11.3 Hz,
1H), 5.41 (d, J ) 17.8 Hz, 1H), 4.54 (d, J ) 1.7 Hz, 1H), 4.51 (t, J )
5.3 Hz, 1H), 4.03 (d, J ) 5.3 Hz, 2H), 0.95 (s, 9H), 0.90 (s, 9H),
0.155 (s, 3H), 0.145 (s, 3H), 0.12 (s, 3H), -0.04 (s, 12H); 13C NMR
(75.5 MHz, CDCl3) δ 164.7, 152.7, 152.4, 149.2, 142.0, 134.9, 133.8,
132.6, 128.7, 127.9, 122.9, 119.0, 90.8, 85.3, 83.9, 82.7, 62.9, 26.0,
25.7, 18.5, 17.9, 2.14, -4.47, -4.75, -5.21, -5.28.
6-N-Benzoyl-9-(2,5-di-O-(tert-butyldimethylsilyl)-3-O-(trimethyl-
silyl)-3-C-formyl-â-D-xylofuranosyl)adenine (12). Crude nucleoside
11 (4.66 g, 6.68 mmol) was dissolved in CH2Cl2 (70 mL) and the
solution was cooled to -78 °C. The reaction flask was then connected
to an ozonolysis apparatus, and ozone (3% O3 in O2, flow 15 mL/min)
was passed through the solution for 1 h. The reaction mixture was
then treated with Me2S (1.47 mL, 20 mmol) and stirred for 2 h at room
temperature. After removal of the solvent in vacuo, the crude product
was purified by FC (eluent: pentane/CH2Cl2/tBuOMe 3:1:1), and 3.10
g (68% from 10) of aldehyde 12 were obtained as a yellowish foam:
Rf ) 0.25 (pentane/CH2Cl2/tBuOMe 3:1:1); 1H NMR (300 MHz, CDCl3)
δ 9.81 (s, 1H), 8.93 (broad s, 1H), 8.80 (s, 1H), 8.23 (s, 1H), 8.03-
8.00 (m, 2H), 7.62-7.50 (m, 3H), 6.16 (s, 1H), 4.98 (dd, J ) 5.3, 8.1
Hz, 1H), 4.67 (s, 1H), 3.93 (m, 2H), 0.945 (s, 9H), 0.87 (s, 9H), 0.27
(s, 3H), 0.105 (s, 3H), 0.10 (s, 3H), 0.07 (s, 3H), 0.003 (s, 9H).
(s, 1H), 8.37 (s, 1H), 8.02-8.00 (m, 2H), 7.59-7.54 (m, 1H), 7.50-
7.44 (m, 2H), 7.38-7.34 (m, 5H), 6.99 (s, 1H), 6.06 (d, J ) 2.2 Hz,
1H), 4.72 (d, J ) 2.2 Hz, 1H), 4.55 (t, J ) 3.7 Hz, 1H), 4.20 (dd, J )
11.8, 3.7 Hz, 1H), 4.04 (dd, J ) 11.8, 3.6 Hz, 1H), 0.92 (s, 9H), 0.80
(s, 9H), 0.12 (s, 3H), 0.10 (s, 3H), 0.04 (s, 3H), -0.02 (s, 3H); 13C
NMR (75.5 MHz, CDCl3) δ 201.2, 164.7, 152.4, 149.7, 149.2, 142.2,
135.7, 133.4, 132.6, 129.0, 128.6, 128.6, 127.8, 126.1, 123.3, 90.6,
90.0, 83.6, 80.9, 62.0, 25.7, 25.4, 18.0, 17.6, -4.78, -5.00, -5.59,
-5.82; FAB-MS (NBA) m/z 787 [M + 4]+, 786 [M + 3]+, 785 [M
+ 2]+, 784 [M + 1]+, 783 M+, 782 [M - 1]+, 781 [M - 2]+, 780 [M
- 3]+ 599 [M + 1 - PhSeCO]+, 598 [M - PhSeCO]+, 240 [ABz +
1]+, 136 [A + 1]+, 105 Bz+; FAB-MS (NBA + KCl) m/z 825 [M +
3 + K]+, 824 [M + 2 + K]+, 823 [M + 1 + K]+, 822 [M + K]+, 821
[M - 1 + K]+, 820 [M - 2 + K]+, 819 [M - 3 + K]+, 818 [M - 4
+ K]+.
6-N-Benzoyl-9-(2-O-(tert-butyldimethylsilyl)-3-C-phenylseleno-
carbonyl-â-D-xylofuranosyl)adenine (15). A solution of selenol ester
14 (50 mg, 64 µmol) and BF3‚Et2O (0.24 mL, 1.92 mmol) in anhydrous
CH2Cl2 (3 mL) was heated under reflux. After 2 h, the mixture was
treated with EtOAc (20 mL) and washed with H2O (3 × 20 mL) and
brine (2 × 10 mL). After removal of the solvent in vacuo, 42 mg
(98%) of selenol ester 15 were obtained as a white solid: 1H NMR
(300 MHz, CDCl3) δ 9.17 (broad s, 1H), 8.81 (s, 1H), 8.01 (s, 1H),
8.04-8.00 (m, 2H), 7.65-7.50 (m, 1H), 7.48-7.39 (m, 7H), 6.66-
6.62 (m, 1H), 5.94 (d, J ) 6.8 Hz, 1H), 5.21 (d, J ) 2.2 Hz, 1H), 5.04
(d, J ) 6.7 Hz, 1H), 4.38 (broad s, 1H), 4.10-4.06 (m, 1H), 3.99-
3.94 (m, 1H), 0.77 (s, 9H), 0.05 (s, 3H), -0.47 (s, 3H).
9-(2-O-(tert-Butyldimethylsilyl)-3-C-phenylselenocarbonyl-â-D-xy-
lofuranosyl)adenine (16). Nucleoside 14 (160 mg, 204 µmol) was
treated with 5% HCl in EtOH (6 mL) for 5 h at 50 °C, then EtOAc (60
mL) was added, and the reaction mixture was washed with H2O (4 ×
30 mL). The combined aqueous phases were extracted with EtOAc
(20 mL), and the organic phases were washed with brine (2 × 20 mL),
dried over Na2SO4, and concentrated under reduced pressure. The crude
product was purified by FC (eluent: CH2Cl2/EtOH 15:1) and 91 mg
(79%) of selenol ester 16 were obtained as a white precipitate: Rf )
0.27 (CH2Cl2/EtOH 15:1); 1H NMR (300 MHz, CDCl3) δ 8.36 (s, 1H),
7.74 (s, 1H), 7.54-7.50 (m, 2H), 7.44-7.39 (m, 3H), 7.24 (dd, J )
10.8, 3.0 Hz, 1H), 5.83 (d, J ) 7.1 Hz, 1H), 5.71 (broad s, 2H), 5.23
(s, 1H), 5.07 (d, J ) 7.1 Hz, 1H), 4.34 (t, J ) 1.6 Hz, 1H), 4.33 (ddd,
J ) 13.4, 2.9, 1.5 Hz, 1H), 3.93 (ddd, J ) 13.3, 11.1, 2.0 Hz, 1H),
0.77 (s, 9H), 0.04 (s, 3H), -0.49 (s, 3H);); 1H NMR (300 MHz, DMSO-
d6) δ 8.39 (s, 1H), 8.17 (s, 1H), 7.80 (s, 1H), 7.47 (broad s, 2H), 7.44-
7.40 (m, 5H), 5.88 (d, J ) 5.3 Hz, 1H), 5.44 (dd, J ) 6.5, 5.0 Hz, 1H),
4.98 (d, J ) 5.3 Hz, 1H), 4.22 (dd, J ) 4.7, 3.8 Hz, 1H), 3.73-3.68
(m, 2H), 0.71 (s, 9H), -0.02 (s, 3H), -0.35 (s, 3H); 13C NMR (75.5
MHz, CDCl3) δ 204.6, 156.0, 148.2, 152.5, 140.8, 136.0, 129.3, 129.0,
128.2, 125.8, 89.0, 88.5, 82.7, 80.9, 62.7, 25.7, 17.7, -4.47, -5.71;
FAB-MS (NBA) m/z 569 [M + 4]+, 568 [M + 3]+, 567 [M + 2]+,
566 [M + 1]+, 565 M+, 564 [M - 1]+, 563 [M - 2]+, 562 [M - 3]+,
381 [M + 1 - PhSeCO]+, 380 [M - PhSeCO]+, 136 [A + 1]+; FAB-
MS (NBA + KCl) m/z 607 [M + 3 + K]+, 606 [M + 2 + K]+, 605
[M + 1 + K]+, 604 [M + K]+, 603 [M - 1 + K]+, 602 [M - 2 +
K]+, 601 [M - 3 + K]+, 600 [M - 4 + K]+.
6-N-Benzoyl-9-(3-C-vinyl-â-D-xylofuranosyl)adenine (17). Nu-
cleoside 10 (5.11 g, 8.16 mmol) was dissolved in anhydrous THF (100
mL) under argon and cooled to 0 °C. The solution was then treated
with TBAF (20.4 mL, 1 M solution in THF) and stirred for 3 h. The
solvent was removed in vacuo, and the residue was purified by FC
(short column with large diameter, eluent: CH2Cl2/MeOH gradient 9:1
f 2:1). A brown oil (3.0 g) was obtained which still contained TBA
salts and which crystallized on standing. Dissolving this mixture in
EtOH and precipitating the product with a 1:1 Et2O/CH2Cl2 mixture
afforded after filtration 2.78 g (82%) of deprotected nucleoside 17 as
a white precipitate: Rf ) 0.41 (CH2Cl2/EtOH 8:1); 1H NMR (300 MHz,
DMSO-d6) δ 11.2 (broad s, 1H), 8.76 (s, 1H), 8.60 (s, 1H), 8.06-8.03
(m, 2H), 7.67-7.61 (m, 1H), 7.57-7.52 (m, 2H), 6.23 (d, J ) 5.4 Hz,
1H), 6.14 (dd, J ) 17.5, 10.9 Hz, 1H), 6.11 (broad s, 1H), 5.51 (s,
1H), 5.43 (dd, J ) 17.5, 1.9 Hz, 1H), 5.31 (dd, J ) 10.9, 1.9 Hz, 1H),
4.81 (t, J ) 5.6 Hz, 1H), 4.18 (dd, J ) 5.4, 1.0 Hz, 1H), 4.12 (dd, J
) 6.8, 2.7 Hz, 1H), 3.75-3.58 (m, 2H); 13C NMR (75.5 MHz, DMSO-
d6) δ 165.6, 151.8, 150.2, 151.5, 143.0, 136.6, 133.4, 132.4, 128.5,
125.6, 115.9, 90.6, 86.0, 82.9, 80.8, 59.5; FAB-MS (NBA) m/z 399
6-N-Benzoyl-9-(2,5-di-O-(tert-butyldimethylsilyl)-3-C-carboxy-â-
D-xylofuranosyl)adenine (13). Aldehyde 12 (75 mg, 107 µmol) was
t
dissolved in a mixture of BuOH (1.5 mL) and phosphate buffer (pH
7, 1 mL). The solution was then stirred with KMnO4 (1 mL of 1 M
aqueous solution) at room temperature. After 2 h, the excess of
permanganate was reduced by addition of saturated aqueous Na2SO3
(2 mL). The reaction mixture was then cooled to 0 °C, carefully
acidified to pH 3 with diluted HCl and extracted with EtOAc (3 × 10
mL). The combined organic phases were dried over MgSO4, treated
with silica gel (0.5 g), and concentrated in vacuo. The residue was
purified by FC (eluent: CH2Cl2/CH3OH/AcOH 100:10:1), and 53 mg
(77%) of carboxylic acid 13 were obtained as a fine white precipitate:
Rf ) 0.30 (CH2Cl2/CH3OH/AcOH 100:10:1); 1H NMR (300 MHz,
acetone-d6) δ 8.70 (s, 1H), 8.68 (s, 1H), 8.15-8.12 (m, 2H), 7.67-
7.53 (m, 3H), 6.30 (d, J ) 3.4 Hz, 1H), 4.87 (d, J ) 3.4 Hz, 1H), 4.69
(t, J ) 4.5 Hz, 1H), 4.11 (d, J ) 4.4 Hz, 2H), 0.92 (s, 9H), 0.83 (s,
1
9H), 0.13 (s, 3H), 0.11 (s, 3H), 0.04 (s, 3H), -0.04 (s, 3H); H NMR
(300 MHz, DMSO-d6) δ 11.2 (s, 1H), 8.76 (s, 1H), 8.60 (s, 1H), 8.05-
8.03 (m, 2H), 7.67-7.61 (m, 1H), 7.57-7.52 (m, 2H), 6.15 (d, J )
3.5 Hz, 1H), 6.12-5.92 (broad s, 1H), 4.69 (d, J ) 3.5 Hz, 1H), 4.50
(t, J ) 4.8 Hz, 1H), 3.94 (d, J ) 4.7 Hz, 2H), 0.86 (s, 9H), 0.77 (s,
9H), 0.05 (s, 3H), 0.03 (s, 3H), -0.02 (s, 3H), -0.10 (s, 3H); 13C NMR
(75.5 MHz, acetone-d6) δ 172.1, 166.2, 152.8, 152.5, 151.1, 143.3,
134.9, 133.2, 129.3, 129.2, 125.4, 89.9, 84.2, 83.9, 83.3, 63.3, 26.3,
25.9, 19.0, 18.3, -4.67, -4.94, -5.05, -5.29.
6-N-Benzoyl-9-(2,5-di-O-(tert-butyldimethylsilyl)-3-C-phenylsele-
nocarbonyl-â-D-xylofuranosyl)adenine (14). A sample of carboxylic
acid 13 (230 mg, 357 µmol) was dissolved in anhydrous DMF (3 mL)
under argon and cooled to 0 °C. 1,1′-Carbonyldi-1,2,4-triazole (147
mg, 893 µmol) was added, and the solution was stirred overnight at
room temperature. The reaction mixture was then cooled to 0 °C and
treated with PhSeH (96.0 µL, 893 µmol). After stirring for 1 h at 0
°C, EtOAc (50 mL) was added, and the mixture was washed with
brine (4 × 30 mL), dried over Na2SO4, and concentrated under re-
duced pressure. The crude product was purified by FC (eluent: EtOAc/
CH2Cl2/pentane 1:1:3), and 220 mg (79%) of selenol ester 14 were
obtained as a fine white precipitate: Rf ) 0.38 (EtOAc/CH2Cl2/pen-
1
tane 1:1:3); H NMR (300 MHz, CDCl3) δ 9.44 (broad s, 1H), 8.78